NouvNeu001 Achieves Milestone with Successful Dosing of First Patient, Signaling Smooth Progress in iRegene Therapeutics’ Multicenter Clinical Trial for Innovative Novel Parkinson’s Disease Therapy
WUHAN, China, Feb. 5, 2024 /PRNewswire/ — iRegene Therapeutics Co., Ltd (iRegene) recently announced that NouvNeu001, the company’s first innovative product, has completed the dosing for its first patient at Beijing Hos… อ่านเพิ่ม